Unusual Myelomas: A Review of IgD and IgE Variants

Although survival of patients with IgD or IgE multiple myeloma is shorter in comparison to those with IgG or IgA multiple myeloma, the outcome for patients with IgD and IgE subtypes is improving with the use of novel agents and autologous transplantation.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news